Paper29550930
Piperacillin and ceftazidime produce the strongest synergistic phage-antibiotic effect in Pseudomonas aeruginosa.
Uchiyama J and 10 others. Arch Virol, 2018. Cited by 69 papers, by iCite.
Cite this record
ConductScience Library. Piperacillin and ceftazidime produce the strongest synergistic phage-antibiotic effect in Pseudomonas aeruginosa. Papers, record 29550930. Release papers-2026-11-12-0.1.0, 12 Nov 2026. https://conductscience.org/library/papers/29550930
- Sources
- 11 sources
- Release
- papers-2026-11-12-0.1.0
Paper
PubMed's record of the paper, with iCite's citation figures. No abstract is shown.
- Title
- Piperacillin and ceftazidime produce the strongest synergistic phage-antibiotic effect in Pseudomonas aeruginosa.
- PubMed
Topics9
NLM's MeSH indexing of the paper, its major topics first.
| MeSH term | Major |
|---|---|
| Anti-Bacterial Agents | Major topic |
| Ceftazidime | Major topic |
| Myoviridae | Major topic |
| Piperacillin | Major topic |
| Pseudomonas Phages | Major topic |
| Pseudomonas aeruginosa | Major topic |
| Humans | |
| Microbial Sensitivity Tests | |
| Phage Therapy |
Source PubMed
Grants1
Each grant PubMed's record writes, matched to the NIH project NIH's grant and paper links name for this paper, and each of those links the record does not write.
| Grant, as the record writes it | Agency | Country | NIH project | Stated by |
|---|---|---|---|---|
| Grant-in-Aid for Young Scientists (15K19095) | Japan Society for the Promotion of Science | PubMed |
Source PubMed
Cited by53
The papers in our copy of PubMed whose reference list names this one, newest first. iCite, which reads more sources, counts 69 citations.
| PMID | Title | Journal | Year | In Papers | Source |
|---|---|---|---|---|---|
| 41750535 | Natural Products as Potentiators of β-Lactam Antibiotics: A Review of Mechanisms, Advances, and Future Directions. | Antioxidants (Basel) | 2026 | https://conductscience.org/library/papers/41750535 | PubMed |
| 41471203 | Characterisation of a Novel Pseudomonas Phage and Its Effect on the Survival of Galleria mellonella Larvae. | Pathogens | 2025 | https://conductscience.org/library/papers/41471203 | PubMed |
| 41039237 | Characterization of bacteriophages PAA and PAM and evaluation of their antibiotic synergy against Pseudomonas aeruginosa PAZMYU isolated from urine sample. | BMC Microbiol | 2025 | https://conductscience.org/library/papers/41039237 | PubMed |
| 40644532 | Wearing bacteriophages individually with an adhesive drug-loadable nanohelmet for treating ocular infections. | Sci Adv | 2025 | https://conductscience.org/library/papers/40644532 | PubMed |
| 40636524 | Combined Forces Against Bacteria: Phages and Antibiotics. | Health Sci Rep | 2025 | https://conductscience.org/library/papers/40636524 | PubMed |
| 40635382 | Phage-Antibiotic Combinations for Pseudomonas: Successes in the Clinic and In Vitro Tenuously Connected. | Microb Biotechnol | 2025 | https://conductscience.org/library/papers/40635382 | PubMed |
| 40575641 | Synergistic efficacy of phages along with vancomycin for eradication of vancomycin-resistant Enterococcus faecalis biofilms. | World J Virol | 2025 | https://conductscience.org/library/papers/40575641 | PubMed |
| 40508147 | Phage-Antibiotic Synergy Enhances Biofilm Eradication and Survival in a Zebrafish Model of Pseudomonas aeruginosa Infection. | Int J Mol Sci | 2025 | https://conductscience.org/library/papers/40508147 | PubMed |
| 40383795 | Phage-antibiotic synergy to combat multidrug resistant strains of Gram-negative ESKAPE pathogens. | Sci Rep | 2025 | https://conductscience.org/library/papers/40383795 | PubMed |
| 40185918 | Bacteriophage Indie resensitizes multidrug-resistant Acinetobacter baumannii to antibiotics in vitro. | Sci Rep | 2025 | https://conductscience.org/library/papers/40185918 | PubMed |
| 40143863 | Phage-antibiotic combinations against Klebsiella pneumoniae: impact of methodological approaches on effect evaluation. | Front Microbiol | 2025 | https://conductscience.org/library/papers/40143863 | PubMed |
| 40114780 | Formulation of Bacteriophage for Inhalation to Treat Multidrug-Resistant Pulmonary Infections. | Kona | 2025 | https://conductscience.org/library/papers/40114780 | PubMed |
| 40013014 | Oral bacteriophages and their potential as adjunctive treatments for periodontitis: a narrative review. | J Oral Microbiol | 2025 | https://conductscience.org/library/papers/40013014 | PubMed |
| 39704503 | Temperate phage-antibiotic synergy is widespread-extending to Pseudomonas-but varies by phage, host strain, and antibiotic pairing. | mBio | 2025 | https://conductscience.org/library/papers/39704503 | PubMed |
| 39334975 | Bacteriophage Therapy on an In Vitro Wound Model and Synergistic Effects in Combination with Beta-Lactam Antibiotics. | Antibiotics (Basel) | 2024 | https://conductscience.org/library/papers/39334975 | PubMed |
| 39066214 | Pseudomonas aeruginosa Bacteriophages and Their Clinical Applications. | Viruses | 2024 | https://conductscience.org/library/papers/39066214 | PubMed |
| 38772946 | Phage Therapy for Respiratory Infections: Opportunities and Challenges. | Lung | 2024 | https://conductscience.org/library/papers/38772946 | PubMed |
| 38757974 | Temperate phage-antibiotic synergy across antibiotic classes reveals new mechanism for preventing lysogeny. | mBio | 2024 | https://conductscience.org/library/papers/38757974 | PubMed |
| 38653744 | Phage-antibiotic combinations to control Pseudomonas aeruginosa-Candida two-species biofilms. | Sci Rep | 2024 | https://conductscience.org/library/papers/38653744 | PubMed |
| 38084971 | Exploiting phage-antibiotic synergies to disrupt Pseudomonas aeruginosa PAO1 biofilms in the context of orthopedic infections. | Microbiol Spectr | 2024 | https://conductscience.org/library/papers/38084971 | PubMed |
Data dates
The date of each source this release read.
- Trials
- 2026-11-12
- Gene search
- 2026-11-11
- Pipelines
- 2026-09-18
None in this release
- Trials
- Comments and corrections
- References
- Genes
- Drugs
- Data
Sources 11
- ChEMBL, through Open TargetsCC BY-SA 3.0
- ClinicalTrials.govNo license stated
- HGNCCC0
- iCiteCC BY 4.0
- NCBI GenePublic domain (US government)
- NIH RePORTER's grant and paper linksPublic domain
- Open TargetsCC0 1.0
- PMC's ID filePublic domain (US government)
- PubMedNLM's terms
- PubTator 3Public domain
- UniProtCC BY 4.0
Each source's terms
- ChEMBL, through Open TargetsCC BY-SA 3.0, for the parts from ChEMBL. Read on 8 Nov 2026 at https://platform-docs.opentargets.org/licence
- ClinicalTrials.govnone stated
- HGNCCC0: https://www.genenames.org/about/license/
- iCiteCC BY 4.0
- NCBI GeneNone named for the file. NCBI says information created by or for the US government on its site is in the public domain, and asks that NLM be acknowledged: https://www.ncbi.nlm.nih.gov/home/about/policies/
- NIH RePORTER's grant and paper linksPublic domain (NIH RePORTER)
- Open TargetsCC0 1.0. Open Targets asks that users cite its latest paper: Buniello et al. 2025, Open Targets Platform: facilitating therapeutic hypotheses building in drug discovery, Nucleic Acids Research 53(D1):D1467, PMID 39657122. Read on 8 Nov 2026 at https://platform-docs.opentargets.org/licence
- PMC's ID fileNone named for the file. NCBI says information created by or for the US government on its site is in the public domain, and asks that NLM be acknowledged: https://www.ncbi.nlm.nih.gov/home/about/policies/
- PubMedNLM's terms
- PubTator 3Public domain
- UniProtCC BY 4.0. UniProt's licence file: "All databases and documents in the UniProt FTP directory may be copied and redistributed freely, without advance permission, provided that this copyright statement is reproduced with each copy." UniProt asks that users cite its latest paper: The UniProt Consortium, UniProt: the Universal Protein Knowledgebase in 2025, Nucleic Acids Research 53:D609-D617, https://doi.org/10.1093/nar/gkae1010. Read on 9 Nov 2026 at https://www.uniprot.org/help/license
ClinicalTrials.gov's data carry an international copyright outside the United States: https://clinicaltrials.gov/about-site/terms-conditions.
For software
Read this paper from software.
The record and each of its lists are JSON, twenty rows a page. No key.
GET https://conductscience.org/api/papers/v1/29550930
GET https://conductscience.org/api/papers/v1/29550930/cited_by?page=2